glycine has been researched along with Thrombophilia in 7 studies
Thrombophilia: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Unstable coronary artery disease is in most cases associated with plaque rupture, activation of the coagulation system and subsequent intracoronary thrombus formation which may cause myocardial cell damage." | 2.71 | Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease. ( Grip, L; Linder, R; Oldgren, J; Siegbahn, A; Thygesen, K; Wallentin, L, 2004) |
| "The composite endpoint of screened deep vein thrombosis (DVT) and symptomatic pulmonary embolism (PE) during prophylaxis did not differ significantly between patients with or without these mutations." | 2.70 | Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. ( Andersson, C; Bylock, A; Eriksson, BI; Frison, L; Gustafsson, D; Larson, G; Lindahl, TL; Wåhlander, K, 2002) |
| "Magnetic resonance imaging showed brain infarction; therefore detailed diagnostic evaluation of thrombophilia markers and genetic testing were performed." | 1.40 | MTHFR C677T and prothrombin G20210A mutations in a woman from Dalmatia with silent brain infarction. . ( Ivica, N; Pintarić, I; Titlić, M, 2014) |
| "The prevalence of thrombophilia is not increased in women with severe OHSS." | 1.32 | Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. ( Balasch, J; Carmona, F; Fábregues, F; Ordinas, A; Reverter, JC; Tàssies, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivica, N | 1 |
| Pintarić, I | 1 |
| Titlić, M | 1 |
| Diz-Kucukkaya, R | 1 |
| Hancer, VS | 1 |
| Artim-Esen, B | 1 |
| Pekcelen, Y | 1 |
| Inanc, M | 1 |
| Djordjevic, V | 1 |
| Mitic, G | 1 |
| Pruner, I | 1 |
| Kovac, M | 1 |
| Radojkovic, D | 1 |
| Oldgren, J | 1 |
| Siegbahn, A | 1 |
| Grip, L | 1 |
| Linder, R | 1 |
| Thygesen, K | 1 |
| Wallentin, L | 1 |
| Fábregues, F | 1 |
| Tàssies, D | 1 |
| Reverter, JC | 1 |
| Carmona, F | 1 |
| Ordinas, A | 1 |
| Balasch, J | 1 |
| Van Aken, H | 1 |
| Bode, C | 1 |
| Darius, H | 1 |
| Diehm, C | 1 |
| Encke, A | 1 |
| Gulba, DC | 1 |
| Haas, S | 1 |
| Hacke, W | 1 |
| Puhl, W | 1 |
| Quante, M | 1 |
| Riess, H | 1 |
| Scharf, R | 1 |
| Schellong, S | 1 |
| Schrör, T | 1 |
| Schulte, KL | 1 |
| Tebbe, U | 1 |
| Wåhlander, K | 1 |
| Larson, G | 1 |
| Lindahl, TL | 1 |
| Andersson, C | 1 |
| Frison, L | 1 |
| Gustafsson, D | 1 |
| Bylock, A | 1 |
| Eriksson, BI | 1 |
2 reviews available for glycine and Thrombophilia
| Article | Year |
|---|---|
The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.
Topics: Alanine; Amino Acid Substitution; Antiphospholipid Syndrome; Factor V; Glycine; Humans; Mutation; Pr | 2010 |
Anticoagulation: the present and future.
Topics: Administration, Oral; Amino Acid Chloromethyl Ketones; Anticoagulants; Arginine; Azetidines; Benzyla | 2001 |
2 trials available for glycine and Thrombophilia
| Article | Year |
|---|---|
Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
Topics: Adult; Aged; Biomarkers; Blood Coagulation; Coronary Artery Disease; Glycine; Heparin; Humans; Middl | 2004 |
Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthropl | 2002 |
3 other studies available for glycine and Thrombophilia
| Article | Year |
|---|---|
MTHFR C677T and prothrombin G20210A mutations in a woman from Dalmatia with silent brain infarction. .
Topics: Alanine; Anticoagulants; Biomarkers; Brain Infarction; Croatia; Cysteine; Female; Glycine; Heterozyg | 2014 |
Are thrombophilia more multifactorial than we thought: report of mosaicism for FII G20210A and novel FII T20061C gene variants.
Topics: Alanine; Biomarkers; Cysteine; Female; Genotype; Glycine; Humans; Hypertension, Pulmonary; Middle Ag | 2012 |
Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Topics: Adult; Alanine; Case-Control Studies; Cost-Benefit Analysis; Factor V; Female; Genetic Testing; Glyc | 2004 |